Press Release
Category Added in a WPeMatico Campaign
-
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
SEZ6 expression exceeds that of approved and emerging ADC targets in SCLC SEZ6 expression is positively correlated with DLL3…
Read More » -
IRIX Unveils Next Generation Human First AI Companion Platform Focused on Privacy, Voice Interaction, and Long Term Continuity
IRIX announces a next generation AI companion platform centered on privacy, voice interaction, continuity, and human centered design. United States,…
Read More » -
Computation Ltd. Reports Rising Demand for Professional IT Support and Computer Repair Services
Computation Ltd., a Toronto-based technology services provider, reports rising demand for IT support and computer repair services across Canada. Businesses…
Read More » -
How AI is Applied in the CNC Machining Process
With the manufacturing industries moving towards digitalisation and intelligent production, artificial intelligence (AI) has been one of the key technologies…
Read More » -
How to Master Video Motion Control for Cinematic AI Videos
Video has become the dominant language of digital communication, and the difference between content that captivates and content that gets…
Read More » -
Real Estate Expert Justus Smith of Keystone Explains Where Real Estate Commission Dollars Go for HelloNation
KEYSTONE, Fla., May 30, 2026 /PRNewswire/ — When selling a home, where do real estate commission dollars actually go? A HelloNation…
Read More » -
MakerWorld’s First User-Initiated Charity Contest Names Winners, Bringing Global Creators’ Goodwill Directly to Cancer Wards
AUGSBURG, Germany, May 30, 2026 /PRNewswire/ — MakerWorld’s first user-initiated charity design contest has completed: winners have now been selected…
Read More » -
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 29, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”, 6990.HK) announced today that at the…
Read More » -
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
CHENGDU, China, May 29, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”, 6990.HK) announced that at the 2026…
Read More »
